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Abstract
Background: Dietary advice is one of the cornerstones in the management of type 2 diabetes mellitus. The
American Diabetes Association recommended a hypocaloric diet for overweight or obese adults with type 2
diabetes in order to induce weight loss. However, there is limited evidence on the optimal approaches to control
hyperglycemia in type 2 diabetes patients. The aim of the present study is to assess the comparative efficacy of
different dietary approaches on glycemic control and blood lipids in patients with type 2 diabetes mellitus in a
systematic review including a standard pairwise and network meta-analysis of randomized trials.
Methods and design: We will conduct searches in Cochrane Central Register of Controlled Trials (CENTRAL) on
the Cochrane Library, PubMed (from 1966), and Google Scholar. Citations, abstracts, and relevant papers will be
screened for eligibility by two reviewers independently. Randomized controlled trials (with a control group or
randomized trials with at least two intervention groups) will be included if they meet the following criteria:
(1) include type 2 diabetes mellitus, (2) include patients aged ≥18 years, (3) include dietary intervention (different
type of diets: e.g., Mediterranean dietary pattern, low-carbohydrate diet, low-fat diet, vegetarian diet, high protein
diet); either hypo, iso-caloric, or ad libitum diets, (4) minimum intervention period of 12 weeks. For each outcome
measure of interest, random effects pairwise and network meta-analyses will be performed in order to determine
the pooled relative effect of each intervention relative to every other intervention in terms of the post-intervention
values (or mean differences between the changes from baseline value scores). Subgroup analyses are planned for
study length, sample size, age, and sex.
Discussion: This systematic review will synthesize the available evidence on the comparative efficacy of different
dietary approaches in the management of glycosylated hemoglobin (primary outcome), fasting glucose, and
cardiovascular risk factors in type 2 diabetes mellitus patients. The results of the present network meta-analysis will
influence evidence-based treatment decisions since it will be fundamental for based recommendations in the
management of type 2 diabetes.
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Background
Type 2 diabetes mellitus (T2DM) is a chronic disease fa-
cing a growing number of cases worldwide, making it
one of the most serious current health problems.
Globally, in 2014 the prevalence of diabetes was esti-
mated to be 9% among adults [1]. Raised blood glucose,
insulin resistance, and low insulin sensitivity are the
main characteristics of T2DM [2].
Dietary advice is one of the cornerstones in the
management of T2DM [3]. The American Diabetes
Association recommends a hypocaloric diet for over-
weight or obese adults with T2DM in order to induce
weight loss [4]. However, there is limited evidence on
the optimal approaches to control hyperglycaemia in
T2DM patients [5]. The most recent nutrition guide-
lines of the American Diabetes Association indicate
that there is uncertainty regarding the optimal pro-
portion of energy coming from carbohydrates, protein,
and fat for patients with T2DM [4]. Emerging evi-
dence suggests that a diet high in monounsaturated
fatty acids is associated with improved glycemic con-
trol [6–8]. Lifestyle changes can prevent the onset of
T2DM as well as its progression. However, due to a
wide array of diabetes-associated complications (such
as cardiovascular diseases, retinopathy, and neur-
opathy), a variety of lifestyle changes should be ex-
plored to achieve a better protective effect [9, 10].
To our knowledge, up to date, no systematic review
and network meta-analysis has been conducted to com-
pare different dietary modifications in the management
of T2DM. Some pairwise meta-analyses have been pub-
lished comparing a higher vs. lower fat diet or different
macronutrient compositions [11–13]. One of the most
important questions that remains to be answered is
which dietary approach offers the most benefits.
Therefore, our aim is to compare the efficacy of differ-
ent dietary approaches on glycemic control and blood
lipids in patients with T2DM in a systematic review
including a pairwise and network meta-analysis of
randomized trials.
Methods and design
The review was registered in PROSPERO International
Prospective Register of Systematic Reviews (https://
www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=
CRD42016047464). The present systematic review
protocol was planned, conducted, and reported in
adherence to standards of quality for reporting system-
atic review and network meta-analysis protocols [14–17]
(Additional file 1).
Eligibility criteria
Studies will be included in the meta-analysis if they meet
all of the following criteria:
Types of studies
Randomized parallel or cross-over studies comparing differ-
ent dietary approaches (e.g., dietary approach to stop hyper-
tension; Mediterranean diet, vegetarian diet, Paleolithic
diet, low-fat diet, low-carbohydrate diet, high protein diet,
low-glycemic index/load diet) with a minimum intervention
period of 3 months will be considered for this review.
Types of participants
We will include studies with participants that are
aged ≥18 years and are diagnosed with type 2 diabetes
using the diagnosis criteria of the American Diabetes
Association or other internationally recognized standards
[18]. Studies including T2DM patients with hypertension
and/or hyperlipidemia will be also included.
Studies including pregnant women, children, and ado-
lescents, patients with normal glucose metabolism, and
chronic renal disease will be excluded [19].
Types of interventions
We will take into account all intervention trials that
meet the abovementioned inclusion criteria and include
at least one of the following intervention diets and a
control, or other intervention diet.
Eligible types of diet will be the following:
 Low-carbohydrate diet (carbohydrates provide <30%
total energy intake, high intake of animal and/or
plant protein, often high intake of fat) [20];
 Low-fat diet (fat provide <30% of total energy intake,
high intake of cereals and grains) [5, 20];
 Vegetarian diet (no meat, poultry, and fish);
 High protein diet (proteins provide >20% of total
energy intake, high intake of animal and/or plant
protein) [21];
 Mediterranean dietary pattern (fruit, vegetables,
olive oil, legumes, cereals, fish, and moderate intake
of red wine during meals) [22–26];
 Dietary approach to stop hypertension (high intake
of fruits and vegetables, low-fat dairy, whole-grain
cereals) [27];
 Low-glycemic index/load diet (glycaemic index
and/or glycaemic load values must have been
reported) [28, 29].
An intervention period of at least 3 months was chosen.
We will include either energy restricted diets, iso-
caloric, or ad libitum diets.
The following dietary regimens will be excluded:
1. Intervention studies solely based on dietary
supplements (e.g., vitamin C, vitamin E, calcium,
potassium, garlic, soy protein) or single foods
(e.g., nuts);
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2. Intervention studies using dietary supplements as
placebo (e.g., protein shakes);
3. Studies with an exercise/medication [30, 31]
co-intervention that was not applied in all the
intervention/control groups;
4. Interventions based on very low-energy diets
(i.e., <600 kcal/day), since the Canadian Diabetes
Association does not recommend the routine use of
very low-calorie diets [32], while the American
Diabetes Association suggests that these should not
be used for more than 3 months without close
supervision of a clinician [33].
Figure 1 shows the network of possible pairwise com-
parisons between the eligible dietary interventions.
Outcome measures
The selected outcome measures represent the most uti-
lized biomarkers for T2DM patients in clinical trials [34].
The primary outcome will be glycosylated hemoglobin
(HbA1c); the following secondary outcome will be consid-
ered: fasting plasma glucose, body weight, total choles-
terol, low-density lipoprotein cholesterol, high-density
lipoprotein cholesterol, and triacylglycerol. All of these
outcomes are evidence-based and validated risk factors for
cardiovascular disease, the main cause of death for T2DM
patients [35].
Blood samples should have been obtained after at least
8 h of overnight of fasting.
Search strategy
The search will be performed by LS and CS, and differ-
ences will be resolved by discussion with a third reviewer
(HB). We will conduct searches in PubMed, Cochrane
CENTRAL, and Google Scholar. We will search for arti-
cles of original research using the following search terms
for PubMed:
#1 diet OR diet[MeSH Terms]
#2 diabetes OR diabetes[MeSH Terms]
#3 (low-carbohydrate[All Fields] OR
high-carbohydrate[All Fields] OR low-fat[All Fields]
OR high-fat[All Fields] OR low-protein[All Fields] OR
high-protein[All Fields] OR vegetarian[All Fields] OR
vegan[All Fields] OR Mediterranean[All Fields] OR
DASH[All Fields] OR dietary approaches to stop
hypertension[All Fields] OR glycaemic index[All Fields]
OR glycaemic load[All Fields] OR Paleolithic[All Fields]
OR low-calorie[All Fields] OR atkins[All Fields])
#4 (glucose[MeSH Terms] OR glycemic[All Fields] OR
glycaemia[All Fields] OR glycaemic[All Fields] OR
glycemia[All Fields] OR HbA1c[All Fields] OR A1c
[All Fields] OR glycated[All Fields] OR
glycosylated[All Fields] OR lipids[MeSH Terms] OR
body weight[MeSH Terms] OR cholesterol*[All
Fields] OR lipid*[All Fields] OR lipoprotein*[All
Fields] OR “high density”[All Fields] OR “low
density” [All Fields] OR triacylglycerol*[All Fields]
OR LDL[All Fields] OR HDL[All Fields])
Fig. 1 Network of all possible pairwise comparisons between the eligible dietary factors
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#5 (randomized controlled trial[All Fields] OR
randomized[All Fields] OR clinical trials as topic[All
Fields] OR placebo[All Fields] OR randomly[All
Fields] OR trial[All Fields] NOT animals[All Fields])
#6 (#1 AND #2 AND #3 AND #4 AND #5)
The search strategy will be adapted for each database.
Moreover, the reference lists from the retrieved original ar-
ticles; systematic reviews and meta-analyses will be checked
to search for further relevant studies. We will also conduct
searches in Clinicaltrials.gov (http://clinicaltrials.gov/) and
the World Health Organization International Clinical
Trials Registry Platform to look for ongoing trials and
opengrey (http://www.opengrey.eu/).
There will be no restrictions by language or publica-
tion year. Studies published in languages other than
English will be translated by international scientists in
our institute.
Study selection process
Two reviewers will screen titles and abstracts of all the
retrieved bibliographic records. Full texts of all poten-
tially eligible records passing the title and abstract
screening level will be retrieved and will be examined in-
dependently by two reviewers with the abovementioned
eligibility criteria/exclusion criteria. Disagreements will
be resolved by consensus or by adjudication of another
author. A flow-diagram will outline the study selection
process and reasons for exclusions for full-text articles.
When a study was published in duplicate, we will in-
clude the version containing the most comprehensive in-
formation (e.g., longest follow-up duration and/or
largest number of study participants).
Data extraction
After determination of the study selection, two reviewers
will extract the following characteristics: the first au-
thor’s last name, year of publication, study design (RCT:
parallel or cross-over), diagnostic criteria for T2DM,
mean baseline age (effect modifier), mean baseline BMI,
mean baseline HbA1c, sex, description of the different
dietary intervention arms, dietary assessment method,
specification of the control group, type of diet (isocaloric
vs. energy restricted vs. ad-libitum), drop outs, adverse
events, and diabetes-associated complications during the
study, and funding source using our own checklist. Pilot-
ing of the tool based on three studies will be performed.
The following outcome measures will be extracted: post-
intervention values or changes from baseline values with
corresponding standard deviations for glycosylated
hemoglobin, fasting plasma glucose, blood lipids: total
cholesterol, low-density lipoprotein cholesterol, high-
density lipoprotein cholesterol, triacylglycerol, and body
weight (effect modifier).
Risk of bias assessment
Full copies of the studies will be independently assessed
by two authors for methodological quality using the risk
of bias assessment tool from the Cochrane Collaboration
[36]. The following sources of bias will be detected: se-
lection bias (random sequence generation and allocation
concealment), performance bias (blinding of participants
and personnel), attrition bias (incomplete outcome data),
reporting bias (selective reporting). Randomized con-
trolled trials in nutrition research are often prone to in-
herent methodological constraints (e.g., they sometimes
cannot be controlled with “true” placebos, but rather by
a limitation of certain aspects of nutrient compositions,
food groups, or dietary patterns).
Studies will be classified as being at low risk of bias
if ≥3 out of a maximum of five risk of bias sub-items were
rated with a low risk of bias by using the risk of bias
assessment tool from the Cochrane Collaboration.
Dealing with missing data
We will try to obtain relevant missing data from authors
of the included RCTs (by e-mail). If the post-intervention
values with the corresponding standard deviations are not
available, the change scores with the corresponding
standard deviations will be imputed, according the guide-
lines of the Cochrane Handbook [37].
Evaluation of synthesis assumptions
Data synthesis
Description of the available data
We will generate descriptive statistics for study and
population characteristics describing the available data
and some important variables (e.g., age, length of follow-
up, outcome relevant baseline risk factors) for each pair-
wise comparison. We will present the available direct
comparisons between different dietary interventions and
control group using a network diagram for each out-
come [38]. The size of the nodes will be proportional to
the sample size to each dietary intervention and the
thickness of the lines proportional to number of studies
available. We will also use the contribution matrix to
identify the direct comparisons with greater influence in
the network relative effects [38, 39].
Standard pairwise meta-analyses and network
meta-analyses
For each outcome measure of interest, random pairwise
effects, and network meta-analyses will be performed in
order to determine the pooled relative effect of each
intervention relative to every other intervention in terms
of the post-intervention values or the changes from
baseline scores of the different dietary interventions.
Separate pairwise meta-analyses will be used first to
compare all the interventions with available direct
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evidence from at least two studies. Heterogeneity be-
tween trial results will be measured using the I2 statistic,
and I2 > 50% will be considered to represent substantial
heterogeneity. Forest plots will be generated to illustrate
the study-specific effect sizes along with a 95% confi-
dence interval (CI). Network meta-analysis will be then
used to synthesize all the available evidence. Network
meta-analysis methods are extensions of the standard
pairwise meta-analysis model that enable a simultaneous
comparison of multiple interventions forming a con-
nected network while preserving the internal random-
ization of individual trials. We will perform a random
effects network meta-analysis for each outcome to esti-
mate all possible pairwise relative effects and we will
obtain a clinically meaningful relative ranking of the dif-
ferent dietary interventions. We will present summary
mean differences in a league table. We will also estimate
the relative ranking of the different diets for each out-
come using the distribution of the ranking probabilities,
and the surface under the cumulative ranking curves
(SUCRA) [40]. For each outcome, we will assume a
common network-specific heterogeneity parameter, and
we will estimate the predictive intervals to assess how
much this heterogeneity affects the relative effects with
respect to the additional uncertainty anticipated in
future studies [41].
Assumption of transitivity
Transitivity is the fundamental assumption of indirect
comparisons and network meta-analysis, and its viola-
tion threatens the validity of the findings obtained from
a network of studies. We are considering the following
effect modifiers: changes in body weight and mean
baseline age. Exercise has been already defined as an
exclusion criteria if not applied in intervention diets and
control groups.
Assessment of inconsistency
To evaluate the presence of statistical inconsistency (i.e.,
disagreement between the different sources of evidence)
in the data, we will employ both local and global ap-
proaches [42]. Specifically, we will use the loop-specific
approach [43] to detect loops of evidence that might
present important inconsistency as well as the node-
splitting approach [44] to detect comparisons for which
direct estimates disagree with indirect evidence from the
entire network. Global methods investigate the presence
of inconsistency jointly from all possible sources in the
network. For this purpose we will use the design-by-
treatment interaction model and the I2 statistic [45, 46].
Subgroup and sensitivity analyses
In case of possible important heterogeneity or inconsist-
ency, we will explore the possible sources using subgroup
and meta-regression analyses. Subgroup analyses are
planned for study length, sample size, age, sex, presence of
comorbidities, and type of pharmaceutical intervention.
We will assess the sensitivity of results for the primary
outcome by analyzing only studies considered being at
low risk of bias.
Small study effects and publication bias
When a sufficient number of studies are available (10 or
more studies), we will use the comparison-adjusted fun-
nel plot [38] to assess the presence of small-study effects
in the network and contour-enhanced funnel plots [47],
to investigate whether funnel plot asymmetry is likely to
be explained by publication bias. We draw inference on
the risk for publication bias based primarily on non-
statistical considerations; hence, by considering how
likely it is that studies may have been conducted but not
published based on the expertise of the investigators in
the field.
We will fit all analyses described in a frequentist
framework using Stata 14.0 [48] (network package [49]),
and we will produce presentation tools with the network
graphs package [50].
Quality of the evidence
We will first use our recently developed NutriGrade tool
to evaluate and judge the meta-evidence for pairwise
comparisons, which has been especially developed for
nutrition research to address specific requirements for
this research field [51]. Then, to infer about the quality
of evidence from the network meta-analysis, we will
combine our judgment about the direct comparisons
with their contributions in the estimation within the net-
work, as described in Salanti et al. [42].
Discussion
This systematic review and network meta-analysis will
be the first to summarize and to compare the effects of
different dietary approaches on glycemic control and
cardiovascular risk factors, using both direct and indirect
evidence. This analysis will show which dietary interven-
tions, if any, might be the most promising in the
management of T2DM. The validity of the results will
be limited by the heterogeneity of the different dietary
interventions. A priori dietary patterns such as the
Mediterranean diet or DASH are most likely assessed via
different scoring systems. Likewise, diets defined by spe-
cific macronutrients will vary with respect to the exact
percentage of fat, carbohydrates, or proteins in total
energy consumption as well as the composition of the
remaining macronutrients, respectively. Nevertheless, we
are confident that this network meta-analysis will con-
tribute to the methodological progress in the field of sys-
tematic reviews, since it will be the first to compare the
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direct and indirect effects of different dietary approaches
in the management of T2DM. The results of the present
network meta-analysis will influence evidence-based
treatment decisions in, since it will be fundamental for
based recommendations in the management of T2DM.
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Additional file 1: PRISMA-P checklist. (DOCX 36 kb)
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